Skip to content

Effect of vitamin E on dysmenorrhea

Evaluation of the effect of vitamin E on pelvic pain reduction in women suffering from primary dysmenorrhea

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT138812222624N4
Enrollment
70
Registered
2010-05-03
Start date
2008-01-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary dysmenorrhea. Primary dysmenorrhoea

Interventions

Intervention 1: vitamin E, 400 IU daily starting 2 days before the beginning of menstruation and continuing for 3 days. Intervention 2: Plecebo prescription.
Treatment - Drugs
Placebo
vitamin E, 400 IU daily starting 2 days before the beginning of menstruation and continuing for 3 days

Sponsors

Investigator
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 25 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: single women aged between 18-25 whose dysmenorrhea started around menarche, without any increase during time, regular menstrual cycles and normal pelvic examination. Exclusion criteria: any surgical operation on pelvic and abdominal areas, history of genital infection or pelvic pain, use of other sedatives during the cycle, history of psychological problems or drug use, abnormal or heavy bleeding, smoking or alcohol consumption, digestive problems, prolonged stress in family or job, known pelvic or uterine anomaly, abnormal ultrasound of uterus and ovaries, possible allergy to vitamin E.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pelvic pain reduction. Timepoint: 2 months later. Method of measurement: VAS.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Maryam Kashanian

Iran University of Medical Sciences

maryamkashanian@yahoo.com+98 21 5563 3244

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026